Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 125, Issue 6, Pages 1178-1187Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2010.04.021
Keywords
Asthma; acute exacerbation; virus
Categories
Funding
- Sanofi-Pasteur
- Medical Research Council
- University of Leicester
- British Medical Association
- Asthma UK
- Imperial College Healthcare NHS Trust
- EU ERC MoRIAE
- Centocor Inc
- National Institute for Health Research
Ask authors/readers for more resources
Viral respiratory infections are the most common cause of an acute asthma exacerbation in both children and adults and represent a significant global health burden. An increasing body of evidence supports the hypothesis that these infections cause a greater degree of morbidity in asthmatic subjects than in the healthy population, emphasizing a discrepancy in the antiviral response of asthmatics. In this review we discuss why such a discrepancy might exist, examining the role of the bronchial epithelium as well as the main inflammatory cells, mediators, and molecular pathways that are involved in the immune response. In addition, the potential impact of virus-induced asthma exacerbations on airway remodelling is reviewed and we explore which therapeutic options might be of benefit in preventing the deterioration of asthma control seen following viral infection. (J Allergy Clin Immunol 2010;125:1178-87.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available